Free Trial

BIO-key International (BKYI) Stock Price, News & Analysis

+0.18 (+10.47%)
(As of 05/24/2024 03:59 PM ET)
Today's Range
50-Day Range
52-Week Range
34,500 shs
Average Volume
102,230 shs
Market Capitalization
$1.44 million
P/E Ratio
Dividend Yield
Price Target
BKYI stock logo

About BIO-key International Stock (NASDAQ:BKYI)

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.

BKYI Stock Price History

BKYI Stock News Headlines

BIO-key International Inc BKYI
BIO-key faces Nasdaq non-compliance notice
BIO-key International Inc
BIO-key International, Inc. (BKYI)
BIO-key Intl Stock (NASDAQ:BKYI) Insider Trades
See More Headlines
Receive BKYI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BIO-key International and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Prepackaged software
Current Symbol
Year Founded


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$7.02 million
Book Value
$11.28 per share


Free Float
Market Cap
$1.44 million
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

BKYI Stock Analysis - Frequently Asked Questions

How have BKYI shares performed in 2024?

BIO-key International's stock was trading at $3.00 at the start of the year. Since then, BKYI shares have decreased by 36.7% and is now trading at $1.90.
View the best growth stocks for 2024 here

When is BIO-key International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 28th 2024.
View our BKYI earnings forecast

How were BIO-key International's earnings last quarter?

BIO-key International, Inc. (NASDAQ:BKYI) issued its quarterly earnings results on Monday, November, 15th. The technology company reported ($2.34) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.98) by $0.36. The technology company earned $1.30 million during the quarter. BIO-key International had a negative net margin of 90.82% and a negative trailing twelve-month return on equity of 136.97%.

When did BIO-key International's stock split?

Shares of BIO-key International reverse split on the morning of Thursday, December 21st 2023. The 1-18 reverse split was announced on Thursday, December 21st 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

What guidance has BIO-key International issued on next quarter's earnings?

BIO-key International issued an update on its FY 2023 earnings guidance on Monday, April, 1st. The company provided EPS guidance of -11.450--11.450 for the period. The company issued revenue guidance of $9.1 million-$9.1 million, compared to the consensus revenue estimate of $10.0 million.

What other stocks do shareholders of BIO-key International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BIO-key International investors own include Biocept (BIOC), T2 Biosystems (TTOO), iBio (IBIO), Onconova Therapeutics (ONTX), Acasti Pharma (ACST), Co-Diagnostics (CODX), Heat Biologics (HTBX), Tonix Pharmaceuticals (TNXP), VBI Vaccines (VBIV) and Inovio Pharmaceuticals (INO).

Who are BIO-key International's major shareholders?

BIO-key International's stock is owned by many different retail and institutional investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include James David Sullivan, Michael W Depasquale and Michael W Depasquale.
View institutional ownership trends

How do I buy shares of BIO-key International?

Shares of BKYI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BKYI) was last updated on 5/27/2024 by Staff

From Our Partners